1,2-distearoyl-sn-glycero-3-phosphocholine

Metabolite details

Identifier

NRJAVPSFFCBXDT-HUESYALOSA-N

InChI Key

NRJAVPSFFCBXDT-HUESYALOSA-N

IUPAC name

(2R)-2,3-bis(octadecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

1,2-distearoyl-sn-glycero-3-phosphocholine

INN name

—

Synonym

1,2-Distearoyl-sn-3-phosphacholine

ChEBI

CHEBI:83718

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• Control_vs_AONFH_Stage_III_IV
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Healthy_Control_vs_Osteoarticular_Tuberculosis
• BSA_Control_vs_AA